Published by Benjamin Chiou on 12th February 2024
(Sharecast News) - RBC Capital Markets has reiterated its 'outperform' rating on Smith & Nephew ahead of the medical devices giant's fourth-quarter results later this month, saying it sees upside risk to current estimates.
URL: http://www.digitallook.com/dl/news/story/34082584/...